113,84
21-февраля-25 15:30:02
15 мин. задержка
Акции
-0,88
-0,77%
Сегодняшний диапазон
113,09 - 115,41
ISIN
N/A
Источник
NYSE
Oxford Immunotec’s T-SPOT Discovery SARS-CoV-2 Test is Used in the UK COVID-19 Human Challenge Study to Investigate the T Cell Response to SARS-CoV-2 Infection
18 май 2021 08:15:00 Источник Nasdaq GlobeNewswire
Oxford Immunotec’s T-SPOT.COVID Test is Used in the COV-AD Clinical Study to Investigate the Immunological Response to SARS-CoV-2 Infection in Patients with Primary and Secondary Antibody Deficiency
11 май 2021 08:15:00 Источник Nasdaq GlobeNewswire
Oxford Immunotec’s T-SPOT Discovery SARS-CoV-2 Test Used in DIRECT Study to Investigate the T Cell Response and COVID Vaccination in Ethnic Minority Groups
29 апр 2021 08:15:00 Источник Nasdaq GlobeNewswire
Oxford Immunotec’s T-SPOT Discovery SARS-CoV-2 Test is Used in UK Com-COV Clinical Trial to Investigate the T Cell Response in Different Combinations of Approved COVID-19 Vaccines for the First and Second Doses
27 апр 2021 08:15:00 Источник Nasdaq GlobeNewswire